Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | UCART123 |
Synonyms | |
Therapy Description |
UCART123 are allogeneic T cells that contain anti-CD123 CAR and an RQR8 depletion ligand, which may result in cytotoxicity of cells expressing CD123 (ASH Meeting, 2016, abstract nr 4039, PMID: 31360087). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
UCART123 | UCART123 are allogeneic T cells that contain anti-CD123 CAR and an RQR8 depletion ligand, which may result in cytotoxicity of cells expressing CD123 (ASH Meeting, 2016, abstract nr 4039, PMID: 31360087). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03190278 | Phase I | UCART123 | Study Evaluating Safety and Efficacy of UCART123 in Patients With Acute Myeloid Leukemia | Recruiting | USA | 0 |
NCT03203369 | Phase I | UCART123 | Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN (ABC123) | Terminated | USA | 0 |